Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-153X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivatives ; volume:12 ; number:1 ; day:22 ; month:10 ; year:2018 ; pages:1-11 ; date:12.2018
Chemistry central journal ; 12, Heft 1 (22.10.2018), 1-11, 12.2018
- Urheber
-
Kumar, Sanjiv
- Beteiligte Personen und Organisationen
-
Singh, Jagbir
Narasimhan, Balasubramanian
Shah, Syed Adnan Ali
Lim, Siong Meng
Ramasamy, Kalavathy
Mani, Vasudevan
SpringerLink (Online service)
- DOI
-
10.1186/s13065-018-0475-5
- URN
-
urn:nbn:de:101:1-2018112518441057253512
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kumar, Sanjiv
- Singh, Jagbir
- Narasimhan, Balasubramanian
- Shah, Syed Adnan Ali
- Lim, Siong Meng
- Ramasamy, Kalavathy
- Mani, Vasudevan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Building shape-focused pharmacophore models for effective docking screening
Combining docking with pharmacophore filtering for improved virtual screening
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations
Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives
A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures
Design, synthesis, pharmacophore modeling, and molecular docking of some novel chloroacetamide derivatives as herbicidal agents
Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
Building shape-focused pharmacophore models for effective docking screening
Combining docking with pharmacophore filtering for improved virtual screening
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations
Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives
A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures
Design, synthesis, pharmacophore modeling, and molecular docking of some novel chloroacetamide derivatives as herbicidal agents
Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
Building shape-focused pharmacophore models for effective docking screening
Combining docking with pharmacophore filtering for improved virtual screening
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations
Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives
A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures
Design, synthesis, pharmacophore modeling, and molecular docking of some novel chloroacetamide derivatives as herbicidal agents